Accuray ROE 2006-2018 | ARAY
Current and historical return on equity (ROE) values for Accuray (ARAY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Accuray ROE for the three months ending December 31, 2018 was -42.74%.
| Accuray ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2018-12-31 | $-0.02B | $0.05B | -51.34% |
| 2018-09-30 | $-0.02B | $0.05B | -50.53% |
| 2018-06-30 | $-0.02B | $0.05B | -50.00% |
| 2018-03-31 | $-0.03B | $0.05B | -58.95% |
| 2017-12-31 | $-0.02B | $0.05B | -50.53% |
| 2017-09-30 | $-0.03B | $0.05B | -59.57% |
| 2017-06-30 | $-0.03B | $0.05B | -60.42% |
| 2017-03-31 | $-0.03B | $0.05B | -60.49% |
| 2016-12-31 | $-0.03B | $0.05B | -45.05% |
| 2016-09-30 | $-0.02B | $0.05B | -37.29% |
| 2016-06-30 | $-0.03B | $0.06B | -40.49% |
| 2016-03-31 | $-0.02B | $0.06B | -36.50% |
| 2015-12-31 | $-0.03B | $0.06B | -40.43% |
| 2015-09-30 | $-0.03B | $0.06B | -43.84% |
| 2015-06-30 | $-0.04B | $0.08B | -53.25% |
| 2015-03-31 | $-0.05B | $0.08B | -54.38% |
| 2014-12-31 | $-0.05B | $0.08B | -53.56% |
| 2014-09-30 | $-0.04B | $0.08B | -45.41% |
| 2014-06-30 | $-0.04B | $0.10B | -37.40% |
| 2014-03-31 | $-0.05B | $0.10B | -45.80% |
| 2013-12-31 | $-0.07B | $0.10B | -67.78% |
| 2013-09-30 | $-0.10B | $0.10B | -80.00% |
| 2013-06-30 | $-0.10B | $0.11B | -75.05% |
| 2013-03-31 | $-0.10B | $0.12B | -64.40% |
| 2012-12-31 | $-0.09B | $0.15B | -47.50% |
| 2012-09-30 | $-0.07B | $0.17B | -33.62% |
| 2012-06-30 | $-0.07B | $0.20B | -32.32% |
| 2012-03-31 | $-0.08B | $0.22B | -33.23% |
| 2011-12-31 | $-0.06B | $0.23B | -28.35% |
| 2011-09-30 | $-0.05B | $0.24B | -23.44% |
| 2011-06-30 | $-0.03B | $0.24B | -14.10% |
| 2011-03-31 | $0.00B | $0.18B | 1.72% |
| 2010-12-31 | $0.01B | $0.18B | 3.53% |
| 2010-09-30 | $0.00B | $0.17B | 0.61% |
| 2010-06-30 | $0.00B | $0.17B | 1.86% |
| 2010-03-31 | $-0.00B | $0.16B | -0.64% |
| 2009-12-31 | $-0.00B | $0.16B | -1.31% |
| 2009-09-30 | $0.00B | $0.16B | 0.00% |
| 2009-06-30 | $0.00B | $0.15B | 0.00% |
| 2009-03-31 | $-0.00B | $0.15B | -0.72% |
| 2008-12-31 | $-0.00B | $0.14B | -0.75% |
| 2008-09-30 | $0.00B | $0.13B | 0.00% |
| 2008-06-30 | $0.01B | $0.13B | 3.77% |
| 2008-03-31 | $0.01B | $0.13B | 4.57% |
| 2007-12-31 | $0.00B | $0.14B | 3.09% |
| 2007-09-30 | $-0.01B | $0.13B | -6.19% |
| 2007-06-30 | $-0.01B | $0.13B | -10.53% |
| 2007-03-31 | $-0.01B | $0.12B | -86.15% |
| 2006-12-31 | $-0.02B | $-0.06B | 152.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.433B | $0.405B |
| ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $101.646B | 22.71 |
| Intuitive Surgical (ISRG) | United States | $62.797B | 59.11 |
| Edwards Lifesciences (EW) | United States | $37.165B | 37.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.805B | 16.10 |
| IDEXX Laboratories (IDXX) | United States | $18.132B | 49.24 |
| ABIOMED (ABMD) | United States | $16.324B | 107.76 |
| Hologic (HOLX) | United States | $13.485B | 20.39 |
| DexCom (DXCM) | United States | $13.192B | 0.00 |
| Teleflex (TFX) | United States | $13.146B | 29.84 |
| Varian Medical Systems (VAR) | United States | $12.050B | 30.10 |
| STERIS (STE) | United Kingdom | $10.343B | 26.58 |
| Masimo (MASI) | United States | $6.869B | 44.54 |
| Penumbra (PEN) | United States | $5.368B | 324.10 |
| LivaNova (LIVN) | United Kingdom | $4.892B | 31.40 |
| Globus Medical (GMED) | United States | $4.712B | 29.54 |
| Integra LifeSciences Holdings (IART) | United States | $4.349B | 21.19 |
| Wright Medical Group (WMGI) | Netherlands | $3.986B | 0.00 |
| Cantel Medical (CMD) | United States | $3.532B | 34.84 |
| Inogen (INGN) | United States | $3.029B | 65.39 |
| Tandem Diabetes Care (TNDM) | United States | $2.955B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.678B | 22.41 |
| Glaukos (GKOS) | United States | $2.417B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.298B | 20.71 |
| OPKO Health (OPK) | United States | $1.677B | 0.00 |
| Nevro (NVRO) | United States | $1.462B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.305B | 207.82 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.220B | 35.25 |
| Luminex (LMNX) | United States | $1.161B | 53.14 |
| Accelerate Diagnostics (AXDX) | United States | $1.073B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.067B | 0.00 |
| Intersect ENT (XENT) | United States | $1.019B | 0.00 |
| CryoLife (CRY) | United States | $0.999B | 108.12 |
| Natus Medical (BABY) | United States | $0.922B | 19.24 |
| Mesa Laboratories (MLAB) | United States | $0.897B | 36.71 |
| AngioDynamics (ANGO) | United States | $0.871B | 28.27 |
| ViewRay (VRAY) | United States | $0.765B | 0.00 |
| Veracyte (VCYT) | United States | $0.754B | 0.00 |
| AxoGen (AXGN) | United States | $0.673B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.632B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.475B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.445B | 0.00 |
| Si-Bone (SIBN) | United States | $0.438B | 0.00 |
| Fluidigm (FLDM) | United States | $0.405B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.372B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.353B | 0.00 |
| Neuronetics (STIM) | United States | $0.316B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.304B | 0.00 |
| Sientra (SIEN) | United States | $0.298B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.298B | 47.80 |
| IRadimed (IRMD) | United States | $0.290B | 61.72 |
| Nuvectra (NVTR) | United States | $0.247B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.179B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.137B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.121B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.093B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.085B | 0.00 |
| EDAP TMS (EDAP) | France | $0.082B | 0.00 |
| ConforMIS (CFMS) | United States | $0.080B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.074B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.067B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Vermillion (VRML) | United States | $0.060B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.056B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.049B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.038B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.034B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.031B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 45.67 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.011B | 0.00 |
| Avinger (AVGR) | United States | $0.010B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
